Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study of Mefloquine and Sulphadoxine-pyrimethamine as Prophylaxis Against Malaria in Pregnant Human Immunodeficiency Virus Positive Patients

NCT02524444 is registered in ClinicalTrials.gov with ORIYOMI OMOTOYOSI AKINYOTU as lead sponsor.

NCT NCT02524444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02524444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study of Mefloquine and Sulphadoxine-pyrimethamine as Prophylaxis Against Malaria in Pregnant Human Immunodeficiency Virus Positive Patients
Lead sponsor
ORIYOMI OMOTOYOSI AKINYOTU
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2015
Completion date
August 31, 2016
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria in pregnant hiv + patients